Icu Medical (ICUI) Cash from Investing Activities (2009 - 2026)
Icu Medical's (ICUI) quarterly Cash from Investing Activities came in at -$20.1 million in Q2 2026, down 110.74% on a YoY basis from $187.5 million in Q2 2025, and down 79.65% quarter-over-quarter from -$11.2 million in Q1 2026.
Analysis
Icu Medical (ICUI) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Icu Medical (ICUI) has reported Cash from Investing Activities for 18 consecutive years, with -$20.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Investing Activities fell 110.74% year-over-year to -$20.1 million; the trailing twelve-month figure through Jun 2026 stood at -$79.8 million (down 165.79% YoY), and the FY2025 full-year result was $122.2 million, up 237.4% from the prior year.
- Cash from Investing Activities slipped to -$20.1 million in Q2 2026 per ICUI's latest filing, from -$11.2 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $187.5 million in Q2 2025 and bottomed at -$1.9 billion in Q1 2022.
- Historically, Cash from Investing Activities has averaged -$110.9 million across 5 years, with a median of -$19.3 million in 2025.
- The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities sank 9792.22% in 2022, then surged 964.18% in 2025.
- Over 5 years, Cash from Investing Activities stood at -$24.0 million in 2022, then decreased by 27.72% to -$30.6 million in 2023, then gained by 13.39% to -$26.5 million in 2024, then jumped by 30.72% to -$18.4 million in 2025, then slipped by 9.49% to -$20.1 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$20.1 million, -$11.2 million, and -$18.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 329.80 Mn |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | -383.65 Mn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | -222.00 Mn |
| 10 | Icu Medical | 3.82 Bn | 3.52 Bn | 235.05 Mn | -20.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20.14 Mn |
| Mar 31, 2026 | -11.21 Mn |
| Dec 31, 2025 | -18.39 Mn |
| Sep 30, 2025 | -30.03 Mn |
| Jun 30, 2025 | 187.46 Mn |
| Mar 31, 2025 | -16.81 Mn |
| Dec 31, 2024 | -26.55 Mn |
| Sep 30, 2024 | -22.86 Mn |
| Jun 30, 2024 | -21.69 Mn |
| Mar 31, 2024 | -17.86 Mn |
| Dec 31, 2023 | -30.65 Mn |
| Sep 30, 2023 | -24.51 Mn |
| Jun 30, 2023 | -17.61 Mn |
| Mar 31, 2023 | -15.18 Mn |
| Dec 31, 2022 | -24.00 Mn |
| Sep 30, 2022 | -12.53 Mn |
| Jun 30, 2022 | -5.19 Mn |
| Mar 31, 2022 | -1.87 Bn |
| Dec 31, 2021 | -32.94 Mn |
| Sep 30, 2021 | -21.09 Mn |